Related Experiment Video
Updated: May 13, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding
Colin John Crooks1, Joe West, Timothy Richard Card
1Division of Epidemiology and Public Health, The University of Nottingham, Nottingham City Hospital, Nottingham, UK. colin.crooks@nottingham.ac.uk
Nongastrointestinal comorbidity significantly increases the risk of upper gastrointestinal bleeding (GIB). This comorbidity contributes more to GIB cases in the population than other known factors, highlighting its importance in patient assessment.
Area of Science:
- Gastroenterology
- Epidemiology
- Internal Medicine
Background:
- Upper gastrointestinal bleeding (GIB) incidence remains high despite reduced peptic ulcer disease and improved H. pylori and NSAID management.
- Increasing nongastrointestinal comorbidity in patients with GIB suggests other contributing factors.
Purpose of the Study:
- To investigate the association between nongastrointestinal comorbidity and the risk of nonvariceal upper gastrointestinal bleeding (GIB).
Main Methods:
- A matched case-control study utilized linked English primary and secondary care data (1997-2010).
- 16,355 patients with nonvariceal GIB were matched with 81,636 controls.
- Conditional logistic regression modeled GIB risk factors, including comorbidity assessed by the Charlson Index.
Main Results:
- Comorbidity showed a graded association with GIB risk (OR 1.43 for single, 2.26 for multiple/severe).
- Comorbidity accounted for a substantial population attributable fraction (19.8%) of GIB cases.
- This contribution exceeded that of aspirin or NSAID use.
Conclusions:
- Nongastrointestinal comorbidity is an independent and significant risk factor for upper gastrointestinal bleeding (GIB).
- Comorbidity explains a larger proportion of GIB cases than previously recognized factors.
- Findings aid GIB cause assessment and explain persistent high incidence in aging populations.
Related Concept Videos
Esophageal Varices-I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...